Resumen de Pharmaceutical industry: Elanco completes acquisition of Novartis

• ELANCO announced on January 5 that it had finalised its acquisition of Novartis Animal Health. The investment was initially announced by its parent company Eli Lilly in April last year (VR, April 26, 2014, vol 174, p 417).

  ‘Elanco's acquisition of Novartis Animal Health brings together two strong companies with a passion for serving the customer,’ said Gaynor Hillier, the company's general manager for the UK and Ireland. ‘We will continue to offer the products our customers trust, while significantly investing in the development of new solutions to meet our customers’ greatest unmet needs.'